AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 65 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,591,000 | +28.2% | 308,217 | -3.2% | 0.00% | – |
| Q2 2020 | $4,360,000 | -54.9% | 318,260 | -53.0% | 0.00% | -100.0% |
| Q1 2020 | $9,674,000 | -14.1% | 676,471 | +1.8% | 0.00% | 0.0% |
| Q4 2019 | $11,258,000 | +18.6% | 664,610 | +7.7% | 0.00% | 0.0% |
| Q3 2019 | $9,494,000 | -44.2% | 616,881 | -15.0% | 0.00% | 0.0% |
| Q2 2019 | $17,017,000 | +3.6% | 725,659 | +25.1% | 0.00% | 0.0% |
| Q1 2019 | $16,427,000 | +66.3% | 579,857 | +76.9% | 0.00% | 0.0% |
| Q4 2018 | $9,880,000 | -20.7% | 327,807 | -7.9% | 0.00% | 0.0% |
| Q3 2018 | $12,461,000 | +102.1% | 355,738 | +36.8% | 0.00% | 0.0% |
| Q2 2018 | $6,167,000 | -7.5% | 260,009 | -0.1% | 0.00% | 0.0% |
| Q1 2018 | $6,664,000 | +49.5% | 260,309 | +1.4% | 0.00% | – |
| Q4 2017 | $4,458,000 | -2.1% | 256,624 | +55.9% | 0.00% | – |
| Q3 2017 | $4,554,000 | – | 164,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|